Skip to main content
Premium Trial:

Request an Annual Quote

Inpharmatica, Serono Extend Proteomics Collaboration

NEW YORK, Aug. 28 (GenomeWeb News) - Inpharmatica said today that its two-year proteomics collaboration with Serono has been extended for an additional year.

The companies first agreed in mid-2001 to the deal, under which Inpharmatica supplies protein sequences to Serono for its drug target discovery efforts. The arrangement was expandedearlier this year to include additional proprietary genomic sequence data from other protein families.

Inpharmatica said that the extension allows Serono to select an unlimited number of novel proteins from those identified, and noted that it comes about two months after the receipt of a milestone payment from Serono triggered by the development of a novel secreted protein.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.